Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sophie Negellen"'
Autor:
Hélène, Denis, Claire, Davoine, Elisabeth, Bermudez, Ghislain, Grosjean, Manon, Schwager, Norbert, Ifrah, Muriel, Dahan, Sophie, Negellen
Publikováno v:
Bulletin du cancer. 106(1)
The offer of anti-cancer drugs has recently been disrupted by the introduction of checkpoint inhibitors on the market. Currently, one anti-CTLA-4, two anti-PD-1 and two anti-PD-L1 are authorized in the European Union, in seven different types of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::acecdfc30a5d41afccbeb89093bd7f6e
https://pubmed.ncbi.nlm.nih.gov/30638899
https://pubmed.ncbi.nlm.nih.gov/30638899
Autor:
Quentin Dardonville, Elisabeth Bermudez, Ghislain Grosjean, Sophie Negellen, Muriel Dahan, Claire Davoine, Norbert Ifrah
Publikováno v:
Journal of Clinical Oncology. 36:e15031-e15031
e15031Background: The launch of CAR-T cells raises major issues in terms of therapeutic strategies, safety, organization of care, financial sustainability. Regarding these challenges and the strong...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6bd3a80c26e3233449cb569fd9cb723
https://doi.org/10.1200/jco.2018.36.15_suppl.e15031
https://doi.org/10.1200/jco.2018.36.15_suppl.e15031
Autor:
Sophie Negellen, L. Escalup, Sandy Blondeel, Anne Pelloquin, Hélène Mullot, Marinette Courbard, Catherine Chenailler
Publikováno v:
Le Pharmacien Hospitalier. 43:189-199
Objectifs Choisir un dispositif securisant la preparation et l’administration des chimiotherapies anticancereuses et en evaluer l’interet sur le plan securitaire, ergonomique et economique. Materiel-methode : Les dispositifs retenus (Phaseal® et
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c507aa0833464c1ef0dda15d91c9cfe4
https://doi.org/10.1016/s0768-9179(08)74962-9
https://doi.org/10.1016/s0768-9179(08)74962-9
Autor:
Hélène Denis, Marianne Duperray, Krol Aurélie, Sophie Negellen, Norbert Ifrah, Thierry Breton, Elisabeth Bermudez
Publikováno v:
Journal of Clinical Oncology. 38(15_suppl):e14134-e14134
e14134 Background: The European joint action iPAAC, funded by the European Commission, aims to develop innovative approaches to advances in cancer control. The field of anticancer drugs has strongly evolved over the past years and the clinical develo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::456e8584c277b04b4efa7cbd446d3059